ATE67479T1 - Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien. - Google Patents

Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.

Info

Publication number
ATE67479T1
ATE67479T1 AT87108737T AT87108737T ATE67479T1 AT E67479 T1 ATE67479 T1 AT E67479T1 AT 87108737 T AT87108737 T AT 87108737T AT 87108737 T AT87108737 T AT 87108737T AT E67479 T1 ATE67479 T1 AT E67479T1
Authority
AT
Austria
Prior art keywords
esters
bronchopneumopathies
phlogistic
treatment
guajakol
Prior art date
Application number
AT87108737T
Other languages
English (en)
Inventor
Angelo Signor
Marino Nicolini
Original Assignee
Finteco Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Finteco Srl filed Critical Finteco Srl
Application granted granted Critical
Publication of ATE67479T1 publication Critical patent/ATE67479T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/90Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified hydroxyl and carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/14Preparation of carboxylic acid esters from carboxylic acid halides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT87108737T 1986-07-03 1987-06-18 Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien. ATE67479T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8621021A IT1213579B (it) 1986-07-03 1986-07-03 Flogistica. esteri di salsalato con guaiacolo atti al trattamento di broncopneumapatie a base
EP87108737A EP0251039B1 (de) 1986-07-03 1987-06-18 Ester von Salsalat mit Guajakol zur Behandlung von phlogistischen Bronchopneumopathien

Publications (1)

Publication Number Publication Date
ATE67479T1 true ATE67479T1 (de) 1991-10-15

Family

ID=11175501

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87108737T ATE67479T1 (de) 1986-07-03 1987-06-18 Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.

Country Status (7)

Country Link
US (1) US4743704A (de)
EP (1) EP0251039B1 (de)
JP (1) JPS6322541A (de)
AT (1) ATE67479T1 (de)
DE (1) DE3773059D1 (de)
ES (1) ES2026485T3 (de)
IT (1) IT1213579B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538033B2 (en) 2000-08-29 2003-03-25 Huntington Medical Research Institutes Nitric oxide donor compounds
JP5759672B2 (ja) 2006-07-09 2015-08-05 テックフィールズ バイオケム カンパニー リミテッド アスピリンの正荷電水溶性プロドラッグ
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
WO2008149181A1 (en) 2007-06-04 2008-12-11 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
RU2630577C2 (ru) 2008-12-04 2017-09-11 Чунси ЮЙ Композиции интенсивного проникновения и их применение
ES2969344T3 (es) 2012-01-18 2024-05-17 Techfields Pharma Co Ltd Composiciones de profármaco de alta penetración y composición farmacéutica del mismo para el tratamiento de afecciones pulmonares

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU446324B2 (en) * 1971-02-04 1974-02-27 Beecham Inc. Chemical processes and products
BE787198A (fr) * 1971-08-07 1973-02-05 Merck Patent Gmbh Composes et melanges nematiques
JPS4954340A (de) * 1972-09-28 1974-05-27
IT1101712B (it) * 1978-11-16 1985-10-07 Bayer Italia Spa Procedimento perfezionato per la preparazione di guaiacolo acetil-salicilato
IT1144813B (it) * 1981-06-22 1986-10-29 Unione Chimica Medicamenti Dif Acetilsalicilato di 2 o metossi fenossi etanolo ad attivita analgesica antipiretica ed antiflogistica e suo metodo di preparazione
US4483854A (en) * 1983-04-12 1984-11-20 Key Pharmaceuticals, Inc. Systemic treatment of psoriasis using certain salicylates

Also Published As

Publication number Publication date
EP0251039A1 (de) 1988-01-07
EP0251039B1 (de) 1991-09-18
JPS6322541A (ja) 1988-01-30
DE3773059D1 (de) 1991-10-24
US4743704A (en) 1988-05-10
IT1213579B (it) 1989-12-20
ES2026485T3 (es) 1992-05-01
IT8621021A0 (it) 1986-07-03

Similar Documents

Publication Publication Date Title
NO951432L (no) Farmasöytiske preparater
DK0606012T3 (da) Sammensætninger indeholdende cholesterylestere af umættede fedtsyrer
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE69219602D1 (de) Pyrazolopyrimidin- und pyrimidinylbisphosphonsäureester als entzündungshemmende mittel
DE3875286D1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
ATE131154T1 (de) Phenylalkan(en)säuren.
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
ATE148628T1 (de) 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten
FI865163A0 (fi) Peptider innehaollande grupper av sulfatester.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE69207387D1 (de) Herstellung von Carbonsäureestern
MY106615A (en) Stabilized leukocyte-interferons.
NO171912C (no) Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyreestere
FR2687667B1 (fr) Esters d'acides carboxyliques d'hydroxyphenylalcanols comme stabilisants.
EP0635010A1 (de) Neue kardioprotektive wirkstoffe.
DE69302718D1 (de) Herstellung von ungesättigten Carbaminsäurederivaten
DE3888505D1 (de) Herstellung von Zimtsäureestern.
DE59006944D1 (de) Verfahren zur Herstellung von 2-Mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren Ester.
DE3768542D1 (de) Herstellung von zimtsaeureestern.
NO166008C (no) Fremgangsmaate for behandling av peroxydblekeavluter.
ES2144429T3 (es) Procedimiento de modificacion de una lipasa.
ATE129636T1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE68913040D1 (de) Herstellungsverfahren von essigsäure arylestern.